Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention and Treatment of Steroid-Induced Osteopenia in Children and Adolescents with Rheumatic Diseases
2005-003129-23Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of risedronate and alfacalcidol in osteopenia, juvenile idiopathic arthritis (JIA), juvenile dermatomyositis (JDM) and 2 more, sponsored by Belfast Health and Social Care Trust. Primary endpoint: Change in bone mineral density at one year. Started Feb 2006; status: completed.
02
Drugs
risedronatealfacalcidol
03
Conditions
osteopeniajuvenile idiopathic arthritis (JIA)juvenile dermatomyositis (JDM)juvenile systemic lupus erythematosus (JSLE)vasculitis
Beyond the preview
Go deeper on 2005-003129-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003129-23.